Test Strips Global Market Report 2025

The test strips market size has grown steadily in recent years. It will grow from $65.95 billion in 2024 to $68.13 billion in 2025 at a compound annual growth rate (CAGR) of 4.9%. Growth during the historical period was driven by the increasing shift toward home-based healthcare, greater emphasis on preventive diagnostics, cost-effectiveness of disposable diagnostic devices, extensive usage in clinical settings, and higher demand for urinalysis testing.

The test strips market size is expected to see steady growth in the next few years. It will grow to $81.13 billion in 2029 at a compound annual growth rate (CAGR) of 4.6%. Projected growth will be fueled by a rising elderly population, increasing prevalence of lifestyle-related health conditions, advancements in miniaturized and smart strip technologies, broader availability through online platforms, and a growing preference for sustainable and biodegradable testing solutions. Key emerging trends include integration with smartphones, multi-analyte testing capabilities, use of AI and machine learning, development of lab-on-a-chip innovations, and application of nanotechnology for improved sensitivity.

The increasing prevalence of diabetes is expected to propel the growth of the test strips market going forward. Diabetes is a chronic medical condition where the body is unable to regulate blood sugar or glucose levels properly. The rise in diabetes cases is largely attributed to sedentary lifestyles, as a lack of physical activity contributes to weight gain and reduced insulin sensitivity, both of which increase the risk of developing the disease. Test strips support diabetes management by offering quick and accurate blood glucose readings, making daily monitoring more effective and convenient. They provide a simple way to track blood sugar levels, facilitating timely treatment decisions and improving overall health outcomes. For example, in June 2024, the National Health Service, a UK-based government department, reported that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, reflecting an 18% increase from 3,065,825 cases in 2022. As a result, the rising prevalence of diabetes is driving growth in the test strips market.

Major companies operating in the test strip market are focusing on the development of advanced products, such as drug detection test strips, to improve detection capabilities, user experience, and accuracy. Drug detection test strips are compact, portable devices designed to rapidly identify the presence of specific drugs or their metabolites in biological samples like urine or saliva. For example, in September 2024, Greenlane Holdings Inc., a US-based cannabis accessories distributor, introduced test strips for detecting fentaNYL, Xylazine, and drink-spiking substances such as benzodiazepines and ketamine. These advanced tools are designed to provide highly sensitive and accurate results within two minutes. Featuring a user-friendly dip-and-read or drop-and-wait format with clear visual indicators, the strips are disposable and easy to use, making them suitable for use in bars, nightclubs, festivals, and personal safety kits.

In February 2025, Safe Supply Streaming Co. Ltd., a Canada-based medical company, acquired Safety Strips Tech Corp. for an undisclosed amount. This acquisition aims to expand Safe Supply Streaming’s product offerings in the diagnostic test strips market, enhance its technological capabilities, and strengthen its presence in key global regions. Safety Strips Tech Corp. is a US-based company specializing in diagnostic test strips for medical use.

Major players in the test strips market are Johnson & Johnson, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Siemens Healthcare GmbH, Becton, Dickinson and Company, TaiDoc Technology Corporation, MilliporeSigma, bioMérieux SA, Bio-Rad Laboratories Inc., B. Braun Melsungen AG, Macherey-Nagel GmbH & Co. KG, OneTouch, EKF Diagnostics Holdings plc, Bionime Corporation, ACON Laboratories Inc., i-SENS Inc., BTNX Inc., ARKRAY Inc., Greenlane Holdings Inc., Safe Supply Streaming Co Ltd.

North America was the largest region in the test strips market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in test strips report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the test strips market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Test strips are compact, disposable tools coated with chemical agents that interact with specific substances found in liquid samples like blood or urine. They are primarily used to deliver fast, convenient, and on-the-spot analysis or measurement of various analytes, assisting in health monitoring or contaminant detection.

The main categories of test strips include blood test strips, urine test strips, and others. Blood test strips are narrow, lightweight devices intended to identify certain chemicals or substances in a small blood sample. These products are distributed through multiple channels, such as online and offline retail, direct sales, hospital procurement networks, and dedicated distributors. Test strips are utilized in numerous applications, including diabetes monitoring, infectious disease screening, cardiac biomarker testing, pregnancy and fertility detection, among others. They serve a wide range of end users like hospitals and clinics, homecare settings, diagnostic laboratories, and more.

The test strips market research report is one of a series of new reports that provides test strips market statistics, including test strips industry global market size, regional shares, competitors with a test strips market share, test strips market segments, market trends and opportunities, and any further data you may need to thrive in the test strips industry. This test strips market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The test strips market consists of sales of glucose test strips, pH test strips, ketone test strips, cholesterol test strips, and drug-of-abuse test strips. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.